PTEN hamartoma tumor syndrome: A personalized healthcare journey

-
Speaker(s): Charis Eng, MD, PhD, FACP
As a physician-scientist for over 20 years, Dr. Eng has dedicated her life to patient-focused research in cancer genetics and genomic medicine. In her dual role as Chair of the Genomic Medicine Institute and Director and staff physician in the Center for Personalized Genetic Healthcare, she continues to implement evidence-based genetic- and genomics-enabled precision healthcare, improving care for patients at genetic risk of disease nationally and globally. Dr. Eng's expertise lies in the genomics of heritable cancers, chief of which are those of the breasts and thyroid. As such, she leads the Germline High Risk Cancer Focus Group of the Case Comprehensive Cancer Center, one of whose thrusts is to prevent heritable cancers. With >500 peer-reviewed articles and >$50 million in lifetime funding from diverse sources, she is an elected member of the National Academy of Medicine and was recently conferred the American Cancer Society Medal of Honor, among numerous awards. In 2019, Dr. Eng was named in the top 0.01% of the most impactful scientists in the world. Her lifelong mentorship has been recently recognized by an American Medical Association Women Physicians' Section Mentorship Recognition and American Medical Women's Association Exceptional Mentor Award. Dr. Eng has served as advisory to DHHS Secretary's Committee on Genetics, Health & Society. She is Editor-in-Chief of Human Molecular Genetics and a Senior Editor of Cancer Research.
Sponsor

Precision Genomics Collaboratory

Co-Sponsor(s)

Center for Statistical Genetics and Genomics (StatGen); Division of Medical Genetics; Duke Center for Applied Genomics and Precision Medicine; Duke Center for Genomic and Computational Biology (GCB); Duke Microbiome Center; Duke Molecular Physiology Institute; School of Medicine (SOM)

PTEN hamartoma tumor syndrome: A personalized healthcare journey

Contact

Jeni Reininga-Craven